Investigating a treatment for Ross River virus infection is just one of the clinical research trials underway at Griffith University’s Clinical Trials Unit designed to improve patient care and health outcomes on the Gold Coast.
It’s an arrangement made possible by the newly signed Memorandum of Understanding between Griffith and Gold Coast Health.
The trial – being run for Paradigm Biopharmaceuticals – is one of several commercially sponsored trials being undertaken at Griffith’s Clinical Trials Unit. The trial is hoping to show that the tested intervention may be useful in providing relief from the often excruciating joint pain associated with Ross River virus infection, which has impacted an average of 220 Gold Coasters each year over the past five years.
Gold Coast Health rheumatologist, Associate Professor Jenni Ng is the principal investigator for the trial.
“It’s a great thing for the Gold Coast community to have access to clinical trials that might improve their

